Recent News

January 4, 2017

GlucoSentient has recently awarded two SBIR Phase I awards for developing point-of-care solution for invasive fungal infections and therapeutic drug monitoring for bipolar disorder.

October 1, 2013

GlucoSentient receives NSF Phase II SBIR grant to continue work on Therapeutic Drug Monitoring.

July 1, 2013

GlucoSentient receives Phase I NIH SBIR award for work in Disease Monitoring.

April 1, 2013

Tian Lan and GlucoSentient receives the NIH SHIFT Award!

October 16, 2012

GlucoSentient completes seed financing

July 1, 2012

GlucoSentient receives Phase I NSF SBIR award for work in Therapeutic Drug Monitoring.

April 10, 2012

GlucoSentient presents at Share the Vision 2012 Technology Showcase at EnterpriseWorks

March 31, 2012

GlucoSentient wins “Best Digital Health Application” 2012 Cozad New Venture Competition! Thanks to Burrill & Company for sponsoring the prize. [Article]

March 20, 2012

Antibody-based assays using personal glucose meters (PGM) published in Analytical Chemistry. [Link]

December 14, 2011

GlucoSentient team graduates from I-CORPS!

Featured Media
GlucoSentient Test Strips